Week In Review: Innovent Lands $305 Million Investment From Sanofi; Will Partner Two Candidates In China
August 06, 2022 at 15:40 PM EDT
Suzhou Innovent Biologics will develop two Sanofi cancer candidates for China use in a complicated deal with money due to each company. Sanofi will initially invest $305 million in Innovent shares.
